Trademarkia Logo

Canada

C$
VANOVA
REGISTERED

on 31 Jan 2022

Last Applicant/ Owned by

GREEN CROSS HOLDINGS CORPORATION A LEGAL ENTITY

107, Ihyeon-ro 30beon-gilGiheung-gu, Yongin-siGyeonggi-do

KR

Serial Number

1859726 filed on 27th Sept 2017

Registration Number

TMA1118940 registered on 31st Jan 2022

Registration expiry Date

31st Jan 2032

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

VANOVA

Trademark usage description

blood plasma-derivatives, namely albumins for use as a therapeutic agent in surgery and blood loss, albumins for use in the manufacture of human vacci Read More

Classification Information


Class [001]
Blood plasma-derivatives, namely albumins for use as a therapeutic agent in surgery and blood loss, albumins for use in the manufacture of human vaccines; recombinant proteins, namely enzymes and blood clotting factors, for use in the medical and pharmaceutical industry, namely, enzymes for use in the manufacture of nutraceuticals, none of which pertaining to raw pharmaceutical or chemical material.


Classification kind code

11

Class [005]
Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; human vaccines, influenza vaccines and vaccine components; therapeutic antibodies for the prevention and treatment of Hepatitis B, influenza, none of which pertaining to raw pharmaceutical or chemical material.


Classification kind code

11

Class [035]
Wholesale distributorships of pharmaceutical products for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; retail store services for pharmaceutical products for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; business agency services, namely, export and import agencies in the field of pharmaceutical products; wholesaling, distributorships in the field of pharmaceutical products, and retailing of pharmaceutical products for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; procurement services for others, namely, purchasing pharmaceutical products for other businesses, none of which pertaining to raw pharmaceutical or chemical material.


Classification kind code

11

Class [036]
Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products ; financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of medical machines and apparatus, none of which pertaining to raw pharmaceutical or chemical material.


Classification kind code

11

Class [042]
Research and development in the field of pharmaceuticals, vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies; laboratory and scientific research in the field of pharmaceuticals, vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies, none of which pertaining to raw pharmaceutical or chemical material.


Classification kind code

11

Mark Details


Serial Number

1859726

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 14th Nov 2019
Approval Notice Sent
Submitted for opposition 26
on 14th Nov 2019
Approved
Submitted for opposition 15
on 7th Oct 2019
Correspondence Created
Submitted for opposition 15
on 8th Mar 2019
Correspondence Created
Submitted for opposition 15
on 28th Feb 2019
Correspondence Created
Submitted for opposition 22
on 2th Oct 2018
Search Recorded
Submitted for opposition 20
on 2th Oct 2018
Examiner's First Report
Submitted for opposition 31
on 29th Sept 2017
Formalized
Submitted for opposition 30
on 27th Sept 2017
Filed
Submitted for opposition 1
on 27th Sept 2017
Created